nodes	percent_of_prediction	percent_of_DWPC	metapath
Aciclovir—Nucleoside Analog—Azathioprine—multiple sclerosis	0.436	1	CiPCiCtD
Aciclovir—Entecavir—Cladribine—multiple sclerosis	0.239	1	CrCrCtD
Aciclovir—SLC47A2—Mitoxantrone—multiple sclerosis	0.162	0.607	CbGbCtD
Aciclovir—SLC47A1—Mitoxantrone—multiple sclerosis	0.0674	0.252	CbGbCtD
Aciclovir—SLC22A1—Cladribine—multiple sclerosis	0.0249	0.0929	CbGbCtD
Aciclovir—SLC22A8—Methotrexate—multiple sclerosis	0.00746	0.0279	CbGbCtD
Aciclovir—SLC22A6—Methotrexate—multiple sclerosis	0.00519	0.0194	CbGbCtD
Aciclovir—Valganciclovir—SLC15A2—multiple sclerosis	0.00109	0.569	CrCbGaD
Aciclovir—Valaciclovir—SLC15A2—multiple sclerosis	0.000823	0.431	CrCbGaD
Aciclovir—SLC47A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC30A7—multiple sclerosis	0.000105	0.0676	CbGpPWpGaD
Aciclovir—SLC10A2—Recycling of bile acids and salts—ALB—multiple sclerosis	9.46e-05	0.0612	CbGpPWpGaD
Aciclovir—SLC22A1—Neurotransmitter Clearance In The Synaptic Cleft—BCHE—multiple sclerosis	8.09e-05	0.0523	CbGpPWpGaD
Aciclovir—SLC47A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—multiple sclerosis	7.31e-05	0.0473	CbGpPWpGaD
Aciclovir—SLC47A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC30A7—multiple sclerosis	6.74e-05	0.0436	CbGpPWpGaD
Aciclovir—SLC47A2—SLC-mediated transmembrane transport—SLC15A2—multiple sclerosis	6.27e-05	0.0405	CbGpPWpGaD
Aciclovir—SLC10A2—Bile acid and bile salt metabolism—ALB—multiple sclerosis	4.94e-05	0.032	CbGpPWpGaD
Aciclovir—Discomfort—Triamcinolone—multiple sclerosis	4.94e-05	0.000903	CcSEcCtD
Aciclovir—Discomfort—Methylprednisolone—multiple sclerosis	4.93e-05	0.000901	CcSEcCtD
Aciclovir—Headache—Azathioprine—multiple sclerosis	4.92e-05	0.0009	CcSEcCtD
Aciclovir—Stevens-Johnson syndrome—Methotrexate—multiple sclerosis	4.92e-05	0.000899	CcSEcCtD
Aciclovir—Renal failure—Methotrexate—multiple sclerosis	4.88e-05	0.000892	CcSEcCtD
Aciclovir—Angioedema—Dexamethasone—multiple sclerosis	4.87e-05	0.00089	CcSEcCtD
Aciclovir—Angioedema—Betamethasone—multiple sclerosis	4.87e-05	0.00089	CcSEcCtD
Aciclovir—Conjunctivitis—Methotrexate—multiple sclerosis	4.82e-05	0.000882	CcSEcCtD
Aciclovir—Confusional state—Methylprednisolone—multiple sclerosis	4.82e-05	0.000881	CcSEcCtD
Aciclovir—Immune system disorder—Prednisone—multiple sclerosis	4.81e-05	0.00088	CcSEcCtD
Aciclovir—Malaise—Betamethasone—multiple sclerosis	4.8e-05	0.000878	CcSEcCtD
Aciclovir—Malaise—Dexamethasone—multiple sclerosis	4.8e-05	0.000878	CcSEcCtD
Aciclovir—Anaphylactic shock—Triamcinolone—multiple sclerosis	4.79e-05	0.000876	CcSEcCtD
Aciclovir—Oedema—Triamcinolone—multiple sclerosis	4.79e-05	0.000876	CcSEcCtD
Aciclovir—Vertigo—Betamethasone—multiple sclerosis	4.79e-05	0.000875	CcSEcCtD
Aciclovir—Vertigo—Dexamethasone—multiple sclerosis	4.79e-05	0.000875	CcSEcCtD
Aciclovir—Anaphylactic shock—Methylprednisolone—multiple sclerosis	4.78e-05	0.000874	CcSEcCtD
Aciclovir—SLC47A2—SLC-mediated transmembrane transport—SLC30A7—multiple sclerosis	4.75e-05	0.0307	CbGpPWpGaD
Aciclovir—Haematuria—Methotrexate—multiple sclerosis	4.73e-05	0.000865	CcSEcCtD
Aciclovir—Insomnia—Prednisolone—multiple sclerosis	4.71e-05	0.000862	CcSEcCtD
Aciclovir—Alopecia—Prednisone—multiple sclerosis	4.71e-05	0.000861	CcSEcCtD
Aciclovir—SLC47A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—multiple sclerosis	4.71e-05	0.0305	CbGpPWpGaD
Aciclovir—Hepatobiliary disease—Methotrexate—multiple sclerosis	4.69e-05	0.000858	CcSEcCtD
Aciclovir—Nervous system disorder—Methylprednisolone—multiple sclerosis	4.69e-05	0.000857	CcSEcCtD
Aciclovir—Hypersensitivity—Mitoxantrone—multiple sclerosis	4.68e-05	0.000856	CcSEcCtD
Aciclovir—Paraesthesia—Prednisolone—multiple sclerosis	4.68e-05	0.000855	CcSEcCtD
Aciclovir—Tachycardia—Triamcinolone—multiple sclerosis	4.68e-05	0.000855	CcSEcCtD
Aciclovir—Nausea—Azathioprine—multiple sclerosis	4.67e-05	0.000853	CcSEcCtD
Aciclovir—Tachycardia—Methylprednisolone—multiple sclerosis	4.67e-05	0.000853	CcSEcCtD
Aciclovir—Skin disorder—Methylprednisolone—multiple sclerosis	4.64e-05	0.000849	CcSEcCtD
Aciclovir—Erythema—Prednisone—multiple sclerosis	4.64e-05	0.000848	CcSEcCtD
Aciclovir—Hyperhidrosis—Triamcinolone—multiple sclerosis	4.63e-05	0.000847	CcSEcCtD
Aciclovir—Hyperhidrosis—Methylprednisolone—multiple sclerosis	4.62e-05	0.000845	CcSEcCtD
Aciclovir—Convulsion—Dexamethasone—multiple sclerosis	4.62e-05	0.000844	CcSEcCtD
Aciclovir—Convulsion—Betamethasone—multiple sclerosis	4.62e-05	0.000844	CcSEcCtD
Aciclovir—Hypertension—Betamethasone—multiple sclerosis	4.6e-05	0.000841	CcSEcCtD
Aciclovir—Hypertension—Dexamethasone—multiple sclerosis	4.6e-05	0.000841	CcSEcCtD
Aciclovir—Asthenia—Mitoxantrone—multiple sclerosis	4.56e-05	0.000833	CcSEcCtD
Aciclovir—Myalgia—Betamethasone—multiple sclerosis	4.54e-05	0.000829	CcSEcCtD
Aciclovir—Myalgia—Dexamethasone—multiple sclerosis	4.54e-05	0.000829	CcSEcCtD
Aciclovir—Discomfort—Dexamethasone—multiple sclerosis	4.48e-05	0.000819	CcSEcCtD
Aciclovir—Discomfort—Betamethasone—multiple sclerosis	4.48e-05	0.000819	CcSEcCtD
Aciclovir—Hypotension—Methylprednisolone—multiple sclerosis	4.47e-05	0.000817	CcSEcCtD
Aciclovir—Pain—Prednisolone—multiple sclerosis	4.46e-05	0.000815	CcSEcCtD
Aciclovir—Hepatitis—Methotrexate—multiple sclerosis	4.45e-05	0.000814	CcSEcCtD
Aciclovir—Urinary tract disorder—Methotrexate—multiple sclerosis	4.4e-05	0.000804	CcSEcCtD
Aciclovir—Urethral disorder—Methotrexate—multiple sclerosis	4.37e-05	0.000798	CcSEcCtD
Aciclovir—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	4.37e-05	0.000798	CcSEcCtD
Aciclovir—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	4.36e-05	0.000796	CcSEcCtD
Aciclovir—Oedema—Dexamethasone—multiple sclerosis	4.35e-05	0.000795	CcSEcCtD
Aciclovir—Oedema—Betamethasone—multiple sclerosis	4.35e-05	0.000795	CcSEcCtD
Aciclovir—Anaphylactic shock—Dexamethasone—multiple sclerosis	4.35e-05	0.000795	CcSEcCtD
Aciclovir—Anaphylactic shock—Betamethasone—multiple sclerosis	4.35e-05	0.000795	CcSEcCtD
Aciclovir—Diarrhoea—Mitoxantrone—multiple sclerosis	4.35e-05	0.000794	CcSEcCtD
Aciclovir—Insomnia—Triamcinolone—multiple sclerosis	4.33e-05	0.000792	CcSEcCtD
Aciclovir—Insomnia—Methylprednisolone—multiple sclerosis	4.32e-05	0.000791	CcSEcCtD
Aciclovir—Ill-defined disorder—Prednisone—multiple sclerosis	4.3e-05	0.000787	CcSEcCtD
Aciclovir—Paraesthesia—Triamcinolone—multiple sclerosis	4.3e-05	0.000787	CcSEcCtD
Aciclovir—Feeling abnormal—Prednisolone—multiple sclerosis	4.29e-05	0.000785	CcSEcCtD
Aciclovir—Paraesthesia—Methylprednisolone—multiple sclerosis	4.29e-05	0.000785	CcSEcCtD
Aciclovir—Anaemia—Prednisone—multiple sclerosis	4.29e-05	0.000784	CcSEcCtD
Aciclovir—Dyspnoea—Triamcinolone—multiple sclerosis	4.27e-05	0.000781	CcSEcCtD
Aciclovir—Nervous system disorder—Dexamethasone—multiple sclerosis	4.26e-05	0.00078	CcSEcCtD
Aciclovir—Nervous system disorder—Betamethasone—multiple sclerosis	4.26e-05	0.00078	CcSEcCtD
Aciclovir—Agitation—Prednisone—multiple sclerosis	4.26e-05	0.000779	CcSEcCtD
Aciclovir—Thrombocytopenia—Dexamethasone—multiple sclerosis	4.26e-05	0.000778	CcSEcCtD
Aciclovir—Thrombocytopenia—Betamethasone—multiple sclerosis	4.26e-05	0.000778	CcSEcCtD
Aciclovir—Tachycardia—Dexamethasone—multiple sclerosis	4.24e-05	0.000776	CcSEcCtD
Aciclovir—Tachycardia—Betamethasone—multiple sclerosis	4.24e-05	0.000776	CcSEcCtD
Aciclovir—Angioedema—Prednisone—multiple sclerosis	4.24e-05	0.000775	CcSEcCtD
Aciclovir—Dyspepsia—Triamcinolone—multiple sclerosis	4.22e-05	0.000771	CcSEcCtD
Aciclovir—Erythema multiforme—Methotrexate—multiple sclerosis	4.21e-05	0.00077	CcSEcCtD
Aciclovir—Dyspepsia—Methylprednisolone—multiple sclerosis	4.21e-05	0.000769	CcSEcCtD
Aciclovir—Hyperhidrosis—Betamethasone—multiple sclerosis	4.2e-05	0.000768	CcSEcCtD
Aciclovir—Hyperhidrosis—Dexamethasone—multiple sclerosis	4.2e-05	0.000768	CcSEcCtD
Aciclovir—Malaise—Prednisone—multiple sclerosis	4.18e-05	0.000765	CcSEcCtD
Aciclovir—Vertigo—Prednisone—multiple sclerosis	4.17e-05	0.000762	CcSEcCtD
Aciclovir—Eye disorder—Methotrexate—multiple sclerosis	4.16e-05	0.000761	CcSEcCtD
Aciclovir—Anorexia—Betamethasone—multiple sclerosis	4.14e-05	0.000758	CcSEcCtD
Aciclovir—Anorexia—Dexamethasone—multiple sclerosis	4.14e-05	0.000758	CcSEcCtD
Aciclovir—Urticaria—Prednisolone—multiple sclerosis	4.14e-05	0.000757	CcSEcCtD
Aciclovir—Fatigue—Triamcinolone—multiple sclerosis	4.13e-05	0.000755	CcSEcCtD
Aciclovir—Fatigue—Methylprednisolone—multiple sclerosis	4.12e-05	0.000754	CcSEcCtD
Aciclovir—Pain—Triamcinolone—multiple sclerosis	4.1e-05	0.000749	CcSEcCtD
Aciclovir—Hypotension—Dexamethasone—multiple sclerosis	4.06e-05	0.000743	CcSEcCtD
Aciclovir—Hypotension—Betamethasone—multiple sclerosis	4.06e-05	0.000743	CcSEcCtD
Aciclovir—SLC47A1—SLC-mediated transmembrane transport—SLC15A2—multiple sclerosis	4.04e-05	0.0261	CbGpPWpGaD
Aciclovir—Vomiting—Mitoxantrone—multiple sclerosis	4.04e-05	0.000738	CcSEcCtD
Aciclovir—Immune system disorder—Methotrexate—multiple sclerosis	4.02e-05	0.000736	CcSEcCtD
Aciclovir—Convulsion—Prednisone—multiple sclerosis	4.02e-05	0.000735	CcSEcCtD
Aciclovir—Mediastinal disorder—Methotrexate—multiple sclerosis	4.01e-05	0.000734	CcSEcCtD
Aciclovir—Hypertension—Prednisone—multiple sclerosis	4.01e-05	0.000732	CcSEcCtD
Aciclovir—Rash—Mitoxantrone—multiple sclerosis	4e-05	0.000732	CcSEcCtD
Aciclovir—Dermatitis—Mitoxantrone—multiple sclerosis	4e-05	0.000731	CcSEcCtD
Aciclovir—Chills—Methotrexate—multiple sclerosis	4e-05	0.000731	CcSEcCtD
Aciclovir—Headache—Mitoxantrone—multiple sclerosis	3.98e-05	0.000727	CcSEcCtD
Aciclovir—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	3.96e-05	0.000724	CcSEcCtD
Aciclovir—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	3.96e-05	0.000724	CcSEcCtD
Aciclovir—Myalgia—Prednisone—multiple sclerosis	3.95e-05	0.000722	CcSEcCtD
Aciclovir—Arthralgia—Prednisone—multiple sclerosis	3.95e-05	0.000722	CcSEcCtD
Aciclovir—Feeling abnormal—Triamcinolone—multiple sclerosis	3.95e-05	0.000722	CcSEcCtD
Aciclovir—Feeling abnormal—Methylprednisolone—multiple sclerosis	3.94e-05	0.00072	CcSEcCtD
Aciclovir—Alopecia—Methotrexate—multiple sclerosis	3.94e-05	0.00072	CcSEcCtD
Aciclovir—Insomnia—Betamethasone—multiple sclerosis	3.93e-05	0.000719	CcSEcCtD
Aciclovir—Insomnia—Dexamethasone—multiple sclerosis	3.93e-05	0.000719	CcSEcCtD
Aciclovir—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	3.92e-05	0.000717	CcSEcCtD
Aciclovir—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	3.91e-05	0.000715	CcSEcCtD
Aciclovir—Paraesthesia—Dexamethasone—multiple sclerosis	3.9e-05	0.000714	CcSEcCtD
Aciclovir—Paraesthesia—Betamethasone—multiple sclerosis	3.9e-05	0.000714	CcSEcCtD
Aciclovir—Discomfort—Prednisone—multiple sclerosis	3.9e-05	0.000713	CcSEcCtD
Aciclovir—Erythema—Methotrexate—multiple sclerosis	3.88e-05	0.000709	CcSEcCtD
Aciclovir—Hypersensitivity—Prednisolone—multiple sclerosis	3.84e-05	0.000702	CcSEcCtD
Aciclovir—Dyspepsia—Dexamethasone—multiple sclerosis	3.83e-05	0.0007	CcSEcCtD
Aciclovir—Dyspepsia—Betamethasone—multiple sclerosis	3.83e-05	0.0007	CcSEcCtD
Aciclovir—Urticaria—Triamcinolone—multiple sclerosis	3.81e-05	0.000696	CcSEcCtD
Aciclovir—Urticaria—Methylprednisolone—multiple sclerosis	3.8e-05	0.000694	CcSEcCtD
Aciclovir—Dysgeusia—Methotrexate—multiple sclerosis	3.8e-05	0.000694	CcSEcCtD
Aciclovir—Body temperature increased—Triamcinolone—multiple sclerosis	3.79e-05	0.000693	CcSEcCtD
Aciclovir—Anaphylactic shock—Prednisone—multiple sclerosis	3.79e-05	0.000692	CcSEcCtD
Aciclovir—Oedema—Prednisone—multiple sclerosis	3.79e-05	0.000692	CcSEcCtD
Aciclovir—Abdominal pain—Methylprednisolone—multiple sclerosis	3.78e-05	0.000691	CcSEcCtD
Aciclovir—Decreased appetite—Dexamethasone—multiple sclerosis	3.78e-05	0.000691	CcSEcCtD
Aciclovir—Decreased appetite—Betamethasone—multiple sclerosis	3.78e-05	0.000691	CcSEcCtD
Aciclovir—Nausea—Mitoxantrone—multiple sclerosis	3.77e-05	0.00069	CcSEcCtD
Aciclovir—Gastrointestinal disorder—Betamethasone—multiple sclerosis	3.75e-05	0.000686	CcSEcCtD
Aciclovir—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	3.75e-05	0.000686	CcSEcCtD
Aciclovir—Fatigue—Betamethasone—multiple sclerosis	3.75e-05	0.000685	CcSEcCtD
Aciclovir—Fatigue—Dexamethasone—multiple sclerosis	3.75e-05	0.000685	CcSEcCtD
Aciclovir—Pain—Betamethasone—multiple sclerosis	3.72e-05	0.00068	CcSEcCtD
Aciclovir—Pain—Dexamethasone—multiple sclerosis	3.72e-05	0.00068	CcSEcCtD
Aciclovir—Nervous system disorder—Prednisone—multiple sclerosis	3.71e-05	0.000679	CcSEcCtD
Aciclovir—Tachycardia—Prednisone—multiple sclerosis	3.7e-05	0.000676	CcSEcCtD
Aciclovir—Skin disorder—Prednisone—multiple sclerosis	3.68e-05	0.000672	CcSEcCtD
Aciclovir—Hyperhidrosis—Prednisone—multiple sclerosis	3.66e-05	0.000669	CcSEcCtD
Aciclovir—Anorexia—Prednisone—multiple sclerosis	3.61e-05	0.00066	CcSEcCtD
Aciclovir—Ill-defined disorder—Methotrexate—multiple sclerosis	3.6e-05	0.000658	CcSEcCtD
Aciclovir—Anaemia—Methotrexate—multiple sclerosis	3.58e-05	0.000655	CcSEcCtD
Aciclovir—Feeling abnormal—Dexamethasone—multiple sclerosis	3.58e-05	0.000655	CcSEcCtD
Aciclovir—Feeling abnormal—Betamethasone—multiple sclerosis	3.58e-05	0.000655	CcSEcCtD
Aciclovir—Gastrointestinal pain—Betamethasone—multiple sclerosis	3.56e-05	0.00065	CcSEcCtD
Aciclovir—Gastrointestinal pain—Dexamethasone—multiple sclerosis	3.56e-05	0.00065	CcSEcCtD
Aciclovir—Hypersensitivity—Triamcinolone—multiple sclerosis	3.53e-05	0.000645	CcSEcCtD
Aciclovir—Hypersensitivity—Methylprednisolone—multiple sclerosis	3.52e-05	0.000644	CcSEcCtD
Aciclovir—Malaise—Methotrexate—multiple sclerosis	3.5e-05	0.000639	CcSEcCtD
Aciclovir—Vertigo—Methotrexate—multiple sclerosis	3.48e-05	0.000637	CcSEcCtD
Aciclovir—Leukopenia—Methotrexate—multiple sclerosis	3.47e-05	0.000635	CcSEcCtD
Aciclovir—Urticaria—Betamethasone—multiple sclerosis	3.45e-05	0.000631	CcSEcCtD
Aciclovir—Urticaria—Dexamethasone—multiple sclerosis	3.45e-05	0.000631	CcSEcCtD
Aciclovir—Musculoskeletal discomfort—Prednisone—multiple sclerosis	3.45e-05	0.000631	CcSEcCtD
Aciclovir—Dizziness—Prednisolone—multiple sclerosis	3.45e-05	0.00063	CcSEcCtD
Aciclovir—Asthenia—Triamcinolone—multiple sclerosis	3.44e-05	0.000629	CcSEcCtD
Aciclovir—Abdominal pain—Betamethasone—multiple sclerosis	3.44e-05	0.000628	CcSEcCtD
Aciclovir—Body temperature increased—Dexamethasone—multiple sclerosis	3.44e-05	0.000628	CcSEcCtD
Aciclovir—Body temperature increased—Betamethasone—multiple sclerosis	3.44e-05	0.000628	CcSEcCtD
Aciclovir—Abdominal pain—Dexamethasone—multiple sclerosis	3.44e-05	0.000628	CcSEcCtD
Aciclovir—Asthenia—Methylprednisolone—multiple sclerosis	3.43e-05	0.000627	CcSEcCtD
Aciclovir—Insomnia—Prednisone—multiple sclerosis	3.42e-05	0.000626	CcSEcCtD
Aciclovir—Paraesthesia—Prednisone—multiple sclerosis	3.4e-05	0.000622	CcSEcCtD
Aciclovir—Pruritus—Triamcinolone—multiple sclerosis	3.39e-05	0.00062	CcSEcCtD
Aciclovir—Pruritus—Methylprednisolone—multiple sclerosis	3.38e-05	0.000618	CcSEcCtD
Aciclovir—Convulsion—Methotrexate—multiple sclerosis	3.36e-05	0.000614	CcSEcCtD
Aciclovir—Dyspepsia—Prednisone—multiple sclerosis	3.33e-05	0.000609	CcSEcCtD
Aciclovir—SLC47A2—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	3.32e-05	0.0215	CbGpPWpGaD
Aciclovir—Arthralgia—Methotrexate—multiple sclerosis	3.3e-05	0.000604	CcSEcCtD
Aciclovir—Myalgia—Methotrexate—multiple sclerosis	3.3e-05	0.000604	CcSEcCtD
Aciclovir—Chest pain—Methotrexate—multiple sclerosis	3.3e-05	0.000604	CcSEcCtD
Aciclovir—Decreased appetite—Prednisone—multiple sclerosis	3.29e-05	0.000602	CcSEcCtD
Aciclovir—Rash—Prednisolone—multiple sclerosis	3.29e-05	0.000601	CcSEcCtD
Aciclovir—Dermatitis—Prednisolone—multiple sclerosis	3.28e-05	0.0006	CcSEcCtD
Aciclovir—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	3.28e-05	0.000599	CcSEcCtD
Aciclovir—Diarrhoea—Methylprednisolone—multiple sclerosis	3.27e-05	0.000598	CcSEcCtD
Aciclovir—Fatigue—Prednisone—multiple sclerosis	3.26e-05	0.000597	CcSEcCtD
Aciclovir—Headache—Prednisolone—multiple sclerosis	3.26e-05	0.000597	CcSEcCtD
Aciclovir—Discomfort—Methotrexate—multiple sclerosis	3.26e-05	0.000596	CcSEcCtD
Aciclovir—Constipation—Prednisone—multiple sclerosis	3.24e-05	0.000592	CcSEcCtD
Aciclovir—Confusional state—Methotrexate—multiple sclerosis	3.19e-05	0.000583	CcSEcCtD
Aciclovir—SLC47A2—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	3.19e-05	0.0206	CbGpPWpGaD
Aciclovir—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC30A7—multiple sclerosis	3.17e-05	0.0205	CbGpPWpGaD
Aciclovir—Dizziness—Triamcinolone—multiple sclerosis	3.17e-05	0.000579	CcSEcCtD
Aciclovir—Anaphylactic shock—Methotrexate—multiple sclerosis	3.16e-05	0.000579	CcSEcCtD
Aciclovir—Dizziness—Methylprednisolone—multiple sclerosis	3.16e-05	0.000578	CcSEcCtD
Aciclovir—Feeling abnormal—Prednisone—multiple sclerosis	3.12e-05	0.00057	CcSEcCtD
Aciclovir—Asthenia—Dexamethasone—multiple sclerosis	3.12e-05	0.00057	CcSEcCtD
Aciclovir—Asthenia—Betamethasone—multiple sclerosis	3.12e-05	0.00057	CcSEcCtD
Aciclovir—Nervous system disorder—Methotrexate—multiple sclerosis	3.1e-05	0.000567	CcSEcCtD
Aciclovir—Thrombocytopenia—Methotrexate—multiple sclerosis	3.1e-05	0.000566	CcSEcCtD
Aciclovir—Gastrointestinal pain—Prednisone—multiple sclerosis	3.1e-05	0.000566	CcSEcCtD
Aciclovir—Nausea—Prednisolone—multiple sclerosis	3.1e-05	0.000566	CcSEcCtD
Aciclovir—Pruritus—Betamethasone—multiple sclerosis	3.08e-05	0.000562	CcSEcCtD
Aciclovir—Pruritus—Dexamethasone—multiple sclerosis	3.08e-05	0.000562	CcSEcCtD
Aciclovir—Skin disorder—Methotrexate—multiple sclerosis	3.07e-05	0.000562	CcSEcCtD
Aciclovir—SLC47A1—SLC-mediated transmembrane transport—SLC30A7—multiple sclerosis	3.06e-05	0.0198	CbGpPWpGaD
Aciclovir—Hyperhidrosis—Methotrexate—multiple sclerosis	3.06e-05	0.000559	CcSEcCtD
Aciclovir—Vomiting—Triamcinolone—multiple sclerosis	3.05e-05	0.000557	CcSEcCtD
Aciclovir—Vomiting—Methylprednisolone—multiple sclerosis	3.04e-05	0.000556	CcSEcCtD
Aciclovir—Rash—Triamcinolone—multiple sclerosis	3.02e-05	0.000552	CcSEcCtD
Aciclovir—Dermatitis—Triamcinolone—multiple sclerosis	3.02e-05	0.000552	CcSEcCtD
Aciclovir—Anorexia—Methotrexate—multiple sclerosis	3.02e-05	0.000551	CcSEcCtD
Aciclovir—Rash—Methylprednisolone—multiple sclerosis	3.01e-05	0.000551	CcSEcCtD
Aciclovir—Dermatitis—Methylprednisolone—multiple sclerosis	3.01e-05	0.000551	CcSEcCtD
Aciclovir—Urticaria—Prednisone—multiple sclerosis	3.01e-05	0.00055	CcSEcCtD
Aciclovir—Headache—Triamcinolone—multiple sclerosis	3e-05	0.000549	CcSEcCtD
Aciclovir—Headache—Methylprednisolone—multiple sclerosis	3e-05	0.000548	CcSEcCtD
Aciclovir—Abdominal pain—Prednisone—multiple sclerosis	2.99e-05	0.000547	CcSEcCtD
Aciclovir—Body temperature increased—Prednisone—multiple sclerosis	2.99e-05	0.000547	CcSEcCtD
Aciclovir—Diarrhoea—Betamethasone—multiple sclerosis	2.97e-05	0.000544	CcSEcCtD
Aciclovir—Diarrhoea—Dexamethasone—multiple sclerosis	2.97e-05	0.000544	CcSEcCtD
Aciclovir—Hypotension—Methotrexate—multiple sclerosis	2.96e-05	0.000541	CcSEcCtD
Aciclovir—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	2.88e-05	0.000527	CcSEcCtD
Aciclovir—Dizziness—Dexamethasone—multiple sclerosis	2.88e-05	0.000526	CcSEcCtD
Aciclovir—Dizziness—Betamethasone—multiple sclerosis	2.88e-05	0.000526	CcSEcCtD
Aciclovir—Insomnia—Methotrexate—multiple sclerosis	2.86e-05	0.000523	CcSEcCtD
Aciclovir—Nausea—Triamcinolone—multiple sclerosis	2.85e-05	0.00052	CcSEcCtD
Aciclovir—Paraesthesia—Methotrexate—multiple sclerosis	2.84e-05	0.000519	CcSEcCtD
Aciclovir—Nausea—Methylprednisolone—multiple sclerosis	2.84e-05	0.000519	CcSEcCtD
Aciclovir—Dyspnoea—Methotrexate—multiple sclerosis	2.82e-05	0.000516	CcSEcCtD
Aciclovir—Somnolence—Methotrexate—multiple sclerosis	2.81e-05	0.000514	CcSEcCtD
Aciclovir—Hypersensitivity—Prednisone—multiple sclerosis	2.79e-05	0.00051	CcSEcCtD
Aciclovir—Dyspepsia—Methotrexate—multiple sclerosis	2.79e-05	0.000509	CcSEcCtD
Aciclovir—Vomiting—Betamethasone—multiple sclerosis	2.76e-05	0.000505	CcSEcCtD
Aciclovir—Vomiting—Dexamethasone—multiple sclerosis	2.76e-05	0.000505	CcSEcCtD
Aciclovir—Decreased appetite—Methotrexate—multiple sclerosis	2.75e-05	0.000503	CcSEcCtD
Aciclovir—Rash—Betamethasone—multiple sclerosis	2.74e-05	0.000501	CcSEcCtD
Aciclovir—Rash—Dexamethasone—multiple sclerosis	2.74e-05	0.000501	CcSEcCtD
Aciclovir—Dermatitis—Betamethasone—multiple sclerosis	2.74e-05	0.000501	CcSEcCtD
Aciclovir—Dermatitis—Dexamethasone—multiple sclerosis	2.74e-05	0.000501	CcSEcCtD
Aciclovir—Gastrointestinal disorder—Methotrexate—multiple sclerosis	2.73e-05	0.000499	CcSEcCtD
Aciclovir—Fatigue—Methotrexate—multiple sclerosis	2.73e-05	0.000499	CcSEcCtD
Aciclovir—Headache—Dexamethasone—multiple sclerosis	2.72e-05	0.000498	CcSEcCtD
Aciclovir—Headache—Betamethasone—multiple sclerosis	2.72e-05	0.000498	CcSEcCtD
Aciclovir—Asthenia—Prednisone—multiple sclerosis	2.72e-05	0.000497	CcSEcCtD
Aciclovir—SLC10A2—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	2.71e-05	0.0175	CbGpPWpGaD
Aciclovir—Pain—Methotrexate—multiple sclerosis	2.71e-05	0.000495	CcSEcCtD
Aciclovir—Pruritus—Prednisone—multiple sclerosis	2.68e-05	0.00049	CcSEcCtD
Aciclovir—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC30A7—multiple sclerosis	2.65e-05	0.0171	CbGpPWpGaD
Aciclovir—SLC10A2—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	2.65e-05	0.0171	CbGpPWpGaD
Aciclovir—SLC10A2—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	2.65e-05	0.0171	CbGpPWpGaD
Aciclovir—Feeling abnormal—Methotrexate—multiple sclerosis	2.61e-05	0.000477	CcSEcCtD
Aciclovir—Diarrhoea—Prednisone—multiple sclerosis	2.59e-05	0.000474	CcSEcCtD
Aciclovir—Gastrointestinal pain—Methotrexate—multiple sclerosis	2.59e-05	0.000473	CcSEcCtD
Aciclovir—Nausea—Dexamethasone—multiple sclerosis	2.58e-05	0.000472	CcSEcCtD
Aciclovir—Nausea—Betamethasone—multiple sclerosis	2.58e-05	0.000472	CcSEcCtD
Aciclovir—Urticaria—Methotrexate—multiple sclerosis	2.51e-05	0.00046	CcSEcCtD
Aciclovir—Dizziness—Prednisone—multiple sclerosis	2.5e-05	0.000458	CcSEcCtD
Aciclovir—Body temperature increased—Methotrexate—multiple sclerosis	2.5e-05	0.000457	CcSEcCtD
Aciclovir—Abdominal pain—Methotrexate—multiple sclerosis	2.5e-05	0.000457	CcSEcCtD
Aciclovir—SLC47A2—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	2.41e-05	0.0156	CbGpPWpGaD
Aciclovir—Vomiting—Prednisone—multiple sclerosis	2.41e-05	0.00044	CcSEcCtD
Aciclovir—Rash—Prednisone—multiple sclerosis	2.39e-05	0.000436	CcSEcCtD
Aciclovir—Dermatitis—Prednisone—multiple sclerosis	2.39e-05	0.000436	CcSEcCtD
Aciclovir—Headache—Prednisone—multiple sclerosis	2.37e-05	0.000434	CcSEcCtD
Aciclovir—Hypersensitivity—Methotrexate—multiple sclerosis	2.33e-05	0.000426	CcSEcCtD
Aciclovir—Asthenia—Methotrexate—multiple sclerosis	2.27e-05	0.000415	CcSEcCtD
Aciclovir—Nausea—Prednisone—multiple sclerosis	2.25e-05	0.000411	CcSEcCtD
Aciclovir—Pruritus—Methotrexate—multiple sclerosis	2.24e-05	0.000409	CcSEcCtD
Aciclovir—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—multiple sclerosis	2.22e-05	0.0143	CbGpPWpGaD
Aciclovir—Diarrhoea—Methotrexate—multiple sclerosis	2.17e-05	0.000396	CcSEcCtD
Aciclovir—SLC47A1—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	2.14e-05	0.0138	CbGpPWpGaD
Aciclovir—Dizziness—Methotrexate—multiple sclerosis	2.09e-05	0.000383	CcSEcCtD
Aciclovir—SLC22A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC30A7—multiple sclerosis	2.06e-05	0.0133	CbGpPWpGaD
Aciclovir—SLC10A2—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	2.05e-05	0.0133	CbGpPWpGaD
Aciclovir—SLC47A1—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	2.05e-05	0.0133	CbGpPWpGaD
Aciclovir—Vomiting—Methotrexate—multiple sclerosis	2.01e-05	0.000368	CcSEcCtD
Aciclovir—Rash—Methotrexate—multiple sclerosis	2e-05	0.000365	CcSEcCtD
Aciclovir—Dermatitis—Methotrexate—multiple sclerosis	1.99e-05	0.000364	CcSEcCtD
Aciclovir—Headache—Methotrexate—multiple sclerosis	1.98e-05	0.000362	CcSEcCtD
Aciclovir—SLC47A2—Transmembrane transport of small molecules—AQP4—multiple sclerosis	1.91e-05	0.0123	CbGpPWpGaD
Aciclovir—SLC22A8—SLC-mediated transmembrane transport—SLC15A2—multiple sclerosis	1.9e-05	0.0123	CbGpPWpGaD
Aciclovir—Nausea—Methotrexate—multiple sclerosis	1.88e-05	0.000344	CcSEcCtD
Aciclovir—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—multiple sclerosis	1.85e-05	0.012	CbGpPWpGaD
Aciclovir—SLC47A2—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	1.69e-05	0.0109	CbGpPWpGaD
Aciclovir—SLC22A1—Neuronal System—KCNA3—multiple sclerosis	1.68e-05	0.0109	CbGpPWpGaD
Aciclovir—SLC10A2—Metabolism—SRM—multiple sclerosis	1.67e-05	0.0108	CbGpPWpGaD
Aciclovir—SLC10A2—Transmembrane transport of small molecules—AQP4—multiple sclerosis	1.62e-05	0.0105	CbGpPWpGaD
Aciclovir—SLC22A6—SLC-mediated transmembrane transport—SLC15A2—multiple sclerosis	1.59e-05	0.0103	CbGpPWpGaD
Aciclovir—SLC47A1—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	1.56e-05	0.0101	CbGpPWpGaD
Aciclovir—SLC22A8—SLC-mediated transmembrane transport—SLC30A7—multiple sclerosis	1.44e-05	0.00933	CbGpPWpGaD
Aciclovir—SLC22A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—multiple sclerosis	1.44e-05	0.0093	CbGpPWpGaD
Aciclovir—SLC10A2—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	1.43e-05	0.00928	CbGpPWpGaD
Aciclovir—SLC22A1—SLC-mediated transmembrane transport—SLC15A2—multiple sclerosis	1.23e-05	0.00798	CbGpPWpGaD
Aciclovir—SLC47A1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	1.23e-05	0.00795	CbGpPWpGaD
Aciclovir—SLC22A6—SLC-mediated transmembrane transport—SLC30A7—multiple sclerosis	1.2e-05	0.00779	CbGpPWpGaD
Aciclovir—SLC47A2—SLC-mediated transmembrane transport—ALB—multiple sclerosis	1.2e-05	0.00773	CbGpPWpGaD
Aciclovir—SLC10A2—Metabolism—CYP27B1—multiple sclerosis	1.18e-05	0.00763	CbGpPWpGaD
Aciclovir—SLC10A2—Metabolism—CYP24A1—multiple sclerosis	1.18e-05	0.00763	CbGpPWpGaD
Aciclovir—SLC10A2—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	1.15e-05	0.00746	CbGpPWpGaD
Aciclovir—SLC47A1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	1.09e-05	0.00703	CbGpPWpGaD
Aciclovir—SLC10A2—Metabolism—GPC5—multiple sclerosis	1.08e-05	0.00698	CbGpPWpGaD
Aciclovir—SLC22A8—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	1.01e-05	0.00652	CbGpPWpGaD
Aciclovir—SLC22A8—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	9.67e-06	0.00626	CbGpPWpGaD
Aciclovir—SLC22A1—SLC-mediated transmembrane transport—SLC30A7—multiple sclerosis	9.35e-06	0.00605	CbGpPWpGaD
Aciclovir—SLC10A2—Metabolism—RRM1—multiple sclerosis	8.94e-06	0.00578	CbGpPWpGaD
Aciclovir—SLC22A6—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	8.41e-06	0.00544	CbGpPWpGaD
Aciclovir—SLC22A6—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	8.07e-06	0.00522	CbGpPWpGaD
Aciclovir—SLC47A1—SLC-mediated transmembrane transport—ALB—multiple sclerosis	7.7e-06	0.00498	CbGpPWpGaD
Aciclovir—SLC22A8—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	7.33e-06	0.00474	CbGpPWpGaD
Aciclovir—SLC10A2—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	6.93e-06	0.00449	CbGpPWpGaD
Aciclovir—SLC22A1—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	6.54e-06	0.00423	CbGpPWpGaD
Aciclovir—SLC22A1—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	6.27e-06	0.00406	CbGpPWpGaD
Aciclovir—SLC22A1—Transmission across Chemical Synapses—BCHE—multiple sclerosis	6.16e-06	0.00399	CbGpPWpGaD
Aciclovir—SLC22A6—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	6.12e-06	0.00396	CbGpPWpGaD
Aciclovir—SLC47A2—Transmembrane transport of small molecules—ALB—multiple sclerosis	6.07e-06	0.00393	CbGpPWpGaD
Aciclovir—SLC10A2—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	5.96e-06	0.00385	CbGpPWpGaD
Aciclovir—SLC22A8—Transmembrane transport of small molecules—AQP4—multiple sclerosis	5.79e-06	0.00375	CbGpPWpGaD
Aciclovir—SLC10A2—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	5.43e-06	0.00351	CbGpPWpGaD
Aciclovir—SLC10A2—Transmembrane transport of small molecules—ALB—multiple sclerosis	5.16e-06	0.00334	CbGpPWpGaD
Aciclovir—SLC10A2—Metabolism—BCHE—multiple sclerosis	5.13e-06	0.00332	CbGpPWpGaD
Aciclovir—SLC22A8—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	5.12e-06	0.00331	CbGpPWpGaD
Aciclovir—SLC22A6—Transmembrane transport of small molecules—AQP4—multiple sclerosis	4.84e-06	0.00313	CbGpPWpGaD
Aciclovir—SLC22A1—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	4.75e-06	0.00307	CbGpPWpGaD
Aciclovir—SLC22A1—Neuronal System—BCHE—multiple sclerosis	4.72e-06	0.00305	CbGpPWpGaD
Aciclovir—SLC22A6—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	4.27e-06	0.00276	CbGpPWpGaD
Aciclovir—SLC47A1—Transmembrane transport of small molecules—ALB—multiple sclerosis	3.91e-06	0.00253	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—SRM—multiple sclerosis	3.88e-06	0.00251	CbGpPWpGaD
Aciclovir—SLC22A1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	3.76e-06	0.00243	CbGpPWpGaD
Aciclovir—SLC22A8—SLC-mediated transmembrane transport—ALB—multiple sclerosis	3.63e-06	0.00235	CbGpPWpGaD
Aciclovir—SLC22A1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	3.32e-06	0.00215	CbGpPWpGaD
Aciclovir—SLC10A2—Metabolism—APOE—multiple sclerosis	3.09e-06	0.002	CbGpPWpGaD
Aciclovir—SLC22A6—SLC-mediated transmembrane transport—ALB—multiple sclerosis	3.03e-06	0.00196	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—CYP27B1—multiple sclerosis	2.73e-06	0.00177	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—CYP24A1—multiple sclerosis	2.73e-06	0.00177	CbGpPWpGaD
Aciclovir—SLC10A2—Metabolism—POMC—multiple sclerosis	2.65e-06	0.00172	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—GPC5—multiple sclerosis	2.5e-06	0.00162	CbGpPWpGaD
Aciclovir—SLC10A2—Metabolism—ALB—multiple sclerosis	2.42e-06	0.00156	CbGpPWpGaD
Aciclovir—SLC22A1—SLC-mediated transmembrane transport—ALB—multiple sclerosis	2.35e-06	0.00152	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—RRM1—multiple sclerosis	2.07e-06	0.00134	CbGpPWpGaD
Aciclovir—SLC22A8—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.84e-06	0.00119	CbGpPWpGaD
Aciclovir—SLC22A1—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	1.8e-06	0.00116	CbGpPWpGaD
Aciclovir—SLC22A6—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.54e-06	0.000995	CbGpPWpGaD
Aciclovir—SLC22A1—Neuronal System—MAPK1—multiple sclerosis	1.38e-06	0.000892	CbGpPWpGaD
Aciclovir—SLC22A1—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.2e-06	0.000774	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—BCHE—multiple sclerosis	1.19e-06	0.000769	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—APOE—multiple sclerosis	7.15e-07	0.000463	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—POMC—multiple sclerosis	6.14e-07	0.000397	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—ALB—multiple sclerosis	5.6e-07	0.000362	CbGpPWpGaD
